TABLE 6.
List of desirable outputs
| Desirable outputs | |
|---|---|
| Transcription_br_cellcycleprogression_Cytosol | VRAP_PlasmaMembrane |
| Anti-apoptosis_Nucleus | Paxillin_PlasmaMembrane |
| ComplexI_kappa_BNF_kappa_B_Intracellular | HSP27_PlasmaMembrane |
| a127_degraded_Intracellular | Tumorsuppression_ |
| CSL_Nuclearmembrane | Survival_ |
| Ets_Nuclearmembrane | Gene_space_transcription_Cytosol |
| STAT3_Nuclearmembrane | Genetranscription_nucleus |
| STAT1_Nuclearmembrane | S6K_cytoplasm |
| TCF_Nuclearmembrane | GSK3_cytoplasm |
| PLD_PlasmaMembrane | Caspase-9_cytoplasm |
| PLA_sub_2_endsub_PlasmaMembrane | BAD_cytoplasm |
| Src_PlasmaMembrane | NOS_cytoplasm |
| Survivin_PlasmaMembrane | ComplexFOXO14-3-3_cytoplasm |
| IGFBP1_nucleus | Cyclind_nucleus |
| Rb_LateG_sub_1_endsub_ | GADD45_nucleus |
| a102_degraded_Mitosis | scl-1_nucleus |
| ComplexeNOSCa_super_2+_endsuper_PlasmaMembrane | ComplexcPLA_sub_2_endsubCa_super_2+_endsuper_PlasmaMembrane |
The flow to these outputs is preserved while devising interference strategies for blocking the formation of complex cJun-cFos.